Common TitlePROTECT: PreHevbrio versus Engerix-B in Healthy Adults
Official Title A Phase 3 Double-Blind Randomized Controlled Trial to Compare the Immunogenicity and Safety of a Three-dose Regimen of Sci-B-Vac® to a Three-dose Regimen of Engerix-B® in Adults (PROTECT)
ClinicalTrials.gov NCT03393754
Treatments
PreHevbrio
PreHevbrio
Tradename:PreHevbrioOther Names:Sci-B-VacTMClass:Vaccines (HBV)Funding
IndustryVBI Vaccines